NM_001388492.1:c.6591G>A
Variant names: 
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001388492.1(HTT):c.6591G>A(p.Glu2197Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.299 in 1,613,220 control chromosomes in the GnomAD database, including 74,997 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.26   (  6032   hom.,  cov: 33) 
 Exomes 𝑓:  0.30   (  68965   hom.  ) 
Consequence
 HTT
NM_001388492.1 synonymous
NM_001388492.1 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  0.0900  
Publications
19 publications found 
Genes affected
 HTT  (HGNC:4851):  (huntingtin) Huntingtin is a disease gene linked to Huntington's disease, a neurodegenerative disorder characterized by loss of striatal neurons. This is thought to be caused by an expanded, unstable trinucleotide repeat in the huntingtin gene, which translates as a polyglutamine repeat in the protein product. A fairly broad range of trinucleotide repeats (9-35) has been identified in normal controls, and repeat numbers in excess of 40 have been described as pathological. The huntingtin locus is large, spanning 180 kb and consisting of 67 exons. The huntingtin gene is widely expressed and is required for normal development. It is expressed as 2 alternatively polyadenylated forms displaying different relative abundance in various fetal and adult tissues. The larger transcript is approximately 13.7 kb and is expressed predominantly in adult and fetal brain whereas the smaller transcript of approximately 10.3 kb is more widely expressed. The genetic defect leading to Huntington's disease may not necessarily eliminate transcription, but may confer a new property on the mRNA or alter the function of the protein. One candidate is the huntingtin-associated protein-1, highly expressed in brain, which has increased affinity for huntingtin protein with expanded polyglutamine repeats. This gene contains an upstream open reading frame in the 5' UTR that inhibits expression of the huntingtin gene product through translational repression. [provided by RefSeq, Jul 2016] 
HTT Gene-Disease associations (from GenCC):
- Huntington diseaseInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
- Lopes-Maciel-Rodan syndromeInheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- juvenile Huntington diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83). 
BP6
Variant 4-3212105-G-A is Benign according to our data. Variant chr4-3212105-G-A is described in ClinVar as Benign. ClinVar VariationId is 1599468.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BP7
Synonymous conserved (PhyloP=0.09 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.376  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.265  AC: 40291AN: 152050Hom.:  6028  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
40291
AN: 
152050
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.295  AC: 73558AN: 249314 AF XY:  0.289   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
73558
AN: 
249314
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.303  AC: 442319AN: 1461052Hom.:  68965  Cov.: 35 AF XY:  0.299  AC XY: 217239AN XY: 726770 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
442319
AN: 
1461052
Hom.: 
Cov.: 
35
 AF XY: 
AC XY: 
217239
AN XY: 
726770
show subpopulations 
African (AFR) 
 AF: 
AC: 
4397
AN: 
33470
American (AMR) 
 AF: 
AC: 
12861
AN: 
44712
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
7836
AN: 
26132
East Asian (EAS) 
 AF: 
AC: 
15266
AN: 
39680
South Asian (SAS) 
 AF: 
AC: 
16363
AN: 
86240
European-Finnish (FIN) 
 AF: 
AC: 
22747
AN: 
53364
Middle Eastern (MID) 
 AF: 
AC: 
748
AN: 
5758
European-Non Finnish (NFE) 
 AF: 
AC: 
344696
AN: 
1111334
Other (OTH) 
 AF: 
AC: 
17405
AN: 
60362
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.483 
Heterozygous variant carriers
 0 
 15788 
 31577 
 47365 
 63154 
 78942 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 11342 
 22684 
 34026 
 45368 
 56710 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.265  AC: 40307AN: 152168Hom.:  6032  Cov.: 33 AF XY:  0.266  AC XY: 19769AN XY: 74398 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
40307
AN: 
152168
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
19769
AN XY: 
74398
show subpopulations 
African (AFR) 
 AF: 
AC: 
6046
AN: 
41526
American (AMR) 
 AF: 
AC: 
3987
AN: 
15282
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1063
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
2020
AN: 
5180
South Asian (SAS) 
 AF: 
AC: 
926
AN: 
4824
European-Finnish (FIN) 
 AF: 
AC: 
4663
AN: 
10570
Middle Eastern (MID) 
 AF: 
AC: 
44
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
20859
AN: 
68002
Other (OTH) 
 AF: 
AC: 
490
AN: 
2112
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.501 
Heterozygous variant carriers
 0 
 1494 
 2987 
 4481 
 5974 
 7468 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 424 
 848 
 1272 
 1696 
 2120 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
1088
AN: 
3478
EpiCase 
 AF: 
EpiControl 
 AF: 
ClinVar
Significance: Benign 
Submissions summary: Benign:2 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:2 
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
 RBP_binding_hub_radar 
 RBP_regulation_power_radar 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.